
Novel anti-SARS-CoV-2 agent, displaying in vitro antiviral activity with IC 50 0.016 µM and Mpro inhibition activity with IC 50 0.013 µM, showing мощный activity against human TMPRSS2 and furin enzymes with IC 50 0.05, and 0.08 µM, respectively
Novel anti-SARS-CoV-2 agent, displaying in vitro antiviral activity with IC 50 0.016 µM and Mpro inhibition activity with IC 50 0.013 µM, showing potent activity against human TMPRSS2 and furin enzymes with IC 50 0.05, and 0.08 µM, respectively
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.